Cytokinetics Inc (CYTK):企業の財務・戦略的SWOT分析

◆英語タイトル:Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15781
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cytokinetics Inc (CYTK) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin activator in Phase 3 for heart failure; and reldesemtiv, a next-generation fast skeletal muscle troponin activator in Phase 2 for the treatment of spinal muscular atrophy; chronic obstructive pulmonary disease; and in Phase 1b for frailty. It is also investigating reldesemtiv for amyotrophic lateral sclerosis. It has licensing agreements with Amgen and Astellas for advancing its drug candidates. Cytokinetics is headquartered in South San Francisco, California, the US.

Cytokinetics Inc Key Recent Developments

Mar 11,2019 Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at ACC.19
Feb 28,2019 Cytokinetics Joins Global Initiative To Recognize International Rare Disease Day
Feb 21,2019 Cytokinetics reports fourth quarter 2018 financial results
Nov 01,2018 Cytokinetics reports third quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Cytokinetics Inc – Key Facts
Cytokinetics Inc – Key Employees
Cytokinetics Inc – Key Employee Biographies
Cytokinetics Inc – Major Products and Services
Cytokinetics Inc – History
Cytokinetics Inc – Company Statement
Cytokinetics Inc – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
Cytokinetics Inc – Business Description
R&D Overview
Cytokinetics Inc – SWOT Analysis
SWOT Analysis – Overview
Cytokinetics Inc – Strengths
Cytokinetics Inc – Weaknesses
Cytokinetics Inc – Opportunities
Cytokinetics Inc – Threats
Cytokinetics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Cytokinetics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 11, 2019: Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at ACC.19
Feb 28, 2019: Cytokinetics Joins Global Initiative To Recognize International Rare Disease Day
Feb 21, 2019: Cytokinetics reports fourth quarter 2018 financial results
Nov 01, 2018: Cytokinetics reports third quarter 2018 financial results
Oct 16, 2018: Cytokinetics Unveils Expanded Development Pipeline and Provides Key Updates on Late-Stage Clinical Research Programs at R&D Day
Oct 05, 2018: Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
Aug 28, 2018: Cytokinetics Awards Inaugural Communications Fellowship To The ALS Association Golden West Chapter
Jul 26, 2018: Cytokinetics Reports Second Quarter 2018 Financial Results
May 17, 2018: Cytokinetics and Cure SMA Renew and Expand Partnership to Advance Education and Awareness of SMA
May 01, 2018: Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Cytokinetics Inc, Key Facts
Cytokinetics Inc, Key Employees
Cytokinetics Inc, Key Employee Biographies
Cytokinetics Inc, Major Products and Services
Cytokinetics Inc, History
Cytokinetics Inc, Key Competitors
Cytokinetics Inc, Ratios based on current share price
Cytokinetics Inc, Annual Ratios
Cytokinetics Inc, Annual Ratios (Cont...1)
Cytokinetics Inc, Interim Ratios
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Cytokinetics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Cytokinetics Inc, Performance Chart (2014 - 2018)
Cytokinetics Inc, Ratio Charts
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Cytokinetics Inc (CYTK):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kuwait Reinsurance Company K.S.C.C.:企業の戦略・SWOT・財務分析
    SummaryKuwait Reinsurance Company K.S.C.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Med BioGene Inc (MBI):企業の財務・戦略的SWOT分析
    Med BioGene Inc (MBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gate Gourmet, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Gate Gourmet, Inc. Mergers and …
  • Qatar National Bank S.A.Q. (QNBK):企業の財務及び戦略的SWOT分析
    Qatar National Bank S.A.Q. (QNBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Crescendo Bioscience Inc-医療機器分野:企業M&A・提携分析
    Summary Crescendo Bioscience Inc (Crescendo), a subsidiary of Myriad Genetics Inc is a molecular diagnostics company that concentrates on rheumatology. The company develops quantitative, objective, and biology based tests for rheumatologists. Its vectra DA is an advanced blood test for rheumatoid ar …
  • PharmaCyte Biotech, Inc. (PMCB):企業のM&A・提携動向(医療機器分野)
    Summary PharmaCyte Biotech, Inc. (PharmaCyte), formerly, Nuvilex, Inc. is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company develops cellulose-based live cell encapsulation technology known as Cell-in-a-Box. Its technology is used …
  • AmpliPhi Biosciences Corporation:企業のM&A・提携・投資分析
    AmpliPhi Biosciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AmpliPhi Biosciences Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • H. Aschehoug and Co. AS:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' H. Aschehoug and Co. AS Mergers …
  • Petron Corp (PCOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Petron Corp (Petron), a subsidiary of San Miguel Corporation, is a downstream energy company. It refines and markets an array of petroleum products including gasoline, liquefied petroleum gas, diesel, jet fuel, kerosene, industrial fuel oil, solvents, asphalts; and petrochemical feedstocks s …
  • U.S. Stem Cell Inc (USRM):企業のM&A・提携動向(医療機器分野)
    Summary U.S. Stem cell Inc (U.S. Stem cell), formerly Bioheart, Inc, is a biotechnology company which focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal …
  • Cardiovascular Systems Inc (CSII):企業財務及び戦略的SWOT分析
    Summary Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for treating peripheral and coronary vascular disease. The company offers products such as peripheral orbital atherectomy system,coronary orbital atherectomy system, crowns, and accessories …
  • Solucom SA (LCO):企業の財務及び戦略的SWOT分析
    Summary Solucom SA (Solucom) is a technology company that provides information technology consulting and management services. The company’s consulting include banking and insurance business transformation, transport and energy business transformation, operational and IT excellence, risk management a …
  • Thai Nakarin Hospital Public Company Ltd (TNH):企業財務及び戦略的SWOT分析
    Summary Thai Nakarin Hospital Public Company Ltd (Thai Nakarin Hospital) is a healthcare service provider that offers primary and healthcare services. The center offers medical services such as heart care, bone and joint care, pediatrics, dental, physical therapy, neurology, gastrointestinal, breast …
  • BeneChill Inc:企業のM&A・提携動向(医療機器分野)
    Summary BeneChill Inc (BeneChill) is a medical device company that develops, manufactures and sells novel rapid cooling technologies. The company offers products such as therapeutic hypothermia and intranasal cooling systems. Its intranasal cooling systems offers cooling that can be initiated by non …
  • Grid2020, Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Navistar International Corporation:企業の戦略、SWOT、動向分析
    The report is a comprehensive, strategic resource on Navistar International Corporation providing key insights, analysis & information on the company. The initial sections provide a snapshot & overview on the business operations & market positioning of the company while the SWOT framework analyzes t …
  • CEMEX, S.A.B. de C.V.:企業のM&A・提携・投資分析
    CEMEX, S.A.B. de C.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CEMEX, S.A.B. de C.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • BioCorRx Inc (BICX):製薬・医療:M&Aディール及び事業提携情報
    Summary BioCorRx Inc (BioCorRx), formerly Fresh Start Private Management Inc, is a healthcare solution provider. The company provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers. It distributes and licenses BioCorRx recovery program, a medication …
  • Thor Mining Plc (THR):企業の財務及び戦略的SWOT分析
    Summary Thor Mining Plc (Thor) is a mineral exploration company that explores and develops gold, tungsten and molybdenum properties. The company’s projects include Molyhil Tungsten and Molybdenum, Spring Hill Gold, Dundas Gold project, and Pilot Mountain Tungsten Project. Its Molyhil Tungsten and Mo …
  • Suffolk Construction Company, Inc.:企業の戦略・SWOT・財務分析
    SummarySuffolk Construction Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆